Protective immune responses to dengue virus infection and vaccines: perspectives from the field to the bench

被引:3
作者
Halstead, Scott B. [1 ]
Zompi, Simone [2 ,3 ]
机构
[1] Int Vaccine Inst, Seoul, South Korea
[2] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA
[3] Immunol & Global Hlth Consulting, Oakland, CA USA
关键词
dengue; antibodies; T cells; myeloid cells; NK cells; immunity; protection; vaccines; NONHUMAN-PRIMATES; EFFICACY; CELLS;
D O I
10.3389/fimmu.2015.00075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:2
相关论文
共 14 条
[1]   A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates [J].
Ambuel, Yuping ;
Young, Ginger ;
Brewoo, Joseph N. ;
Paykel, Joanna ;
Weisgrau, Kim L. ;
Rakasz, Eva G. ;
Haller, Aurelia A. ;
Royals, Michael ;
Huang, Claire Y. -H. ;
Capuano, Saverio ;
Stinchcomb, Dan T. ;
Partidos, Charalambos D. ;
Osorio, Jorge E. .
FRONTIERS IN IMMUNOLOGY, 2014, 5 :1-8
[2]   NK cells during dengue disease and their recognition of dengue virus-infected cells [J].
Beltran, Davis ;
Lopez-Verges, Sandra .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[3]   Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial [J].
Capeding, Maria Rosario ;
Ngoc Huu Tran ;
Hadinegoro, Sri Rezeki S. ;
Ismail, Hussain Imam H. J. Muhammad ;
Chotpitayasunondh, Tawee ;
Chua, Mary Noreen ;
Chan Quang Luong ;
Rusmil, Kusnandi ;
Wirawan, Dewa Nyoman ;
Nallusamy, Revathy ;
Pitisuttithum, Punnee ;
Thisyakorn, Usa ;
Yoon, In-Kyu ;
van der Vliet, Diane ;
Langevin, Edith ;
Laot, Thelma ;
Hutagalung, Yanee ;
Frago, Carina ;
Boaz, Mark ;
Wartel, T. Anh ;
Tornieporth, Nadia G. ;
Saville, Melanie ;
Bouckenooghe, Alain .
LANCET, 2014, 384 (9951) :1358-1365
[4]   Human to mosquito transmiss on of dengue viruses [J].
Carrington, Lauren B. ;
Simmons, Cameron P. .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[5]   Human immune responses to dengue virus infection: lessons learned from prospective cohort studies [J].
Endy, Timothy P. .
FRONTIERS IN IMMUNOLOGY, 2014, 5 :1-6
[6]   Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections [J].
Grange, Laura ;
Simon-Loriere, Etienne ;
Sakuntabhai, Anavaj ;
Gresh, Lionel ;
Paul, Richard ;
Harris, Eva .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[7]   Control of acute dengue virus infection by natural killer cells [J].
Petitdemangew, Caroline ;
WauquierA, Nadia ;
Rey, Juliana ;
Hervier, Baptiste ;
Leroy, Eric ;
Vieillard, Vincent .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[8]   Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial [J].
Sabchareon, Arunee ;
Wallace, Derek ;
Sirivichayakul, Chukiat ;
Limkittikul, Kriengsak ;
Chanthavanich, Pornthep ;
Suvannadabba, Saravudh ;
Jiwariyavej, Vithaya ;
Dulyachai, Wut ;
Pengsaa, Krisana ;
Wartel, T. Anh ;
Moureau, Annick ;
Saville, Melanie ;
Bouckenooghe, Alain ;
Viviani, Simonetta ;
Tornieporth, Nadia G. ;
Lang, Jean .
LANCET, 2012, 380 (9853) :1559-1567
[9]   Utility, limitations, and future of non-human primates for dengue research and vaccine development [J].
Sariol, Carlos A. ;
White, Laura J. .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[10]   Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity [J].
Schmid, Michael A. ;
Diamond, Michael S. ;
Harris, Eva .
FRONTIERS IN IMMUNOLOGY, 2014, 5